Caption Management, LLC
13F filer · CIK 0001706766Reported Aug 14, 2026
Net buyer this quarter
13F portfolio value$21.5BU.S. long equity reported on 13F
Positions507226 new · 222 closed
Net flow last quarter+$277MBuys minus sells
Top 10 positions weight6.7%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 2026507 positions | |||||
| $368M | 1.71% | 0.01% | +22.0% | Q4 2021 | |
| $270M | 1.26% | 0.00% | Not reported | Q4 2020 | |
| $192M | 0.90% | 0.01% | +1931.6% | Q4 2019 | |
| $167M | 0.78% | 0.01% | +32.7% | Q3 2021 | |
| $140M | 0.65% | 232.67% | +5.8% | Q2 2022 | |
| $102M | 0.48% | 0.00% | -16.7% | Q1 2020 | |
| $65.6M | 0.31% | Not reported | Not reported | Q2 2024 | |
| $64.6M | 0.30% | Not reported | +14551.2% | Q3 2020 | |
| $38.9M | 0.18% | 0.01% | -6.5% | Q1 2025 | |
| $34.4M | 0.16% | 0.55% | +28.0% | Q4 2025 | |
| $25.6M | 0.12% | 0.05% | -60.8% | Q1 2018 | |
| $25.2M | 0.12% | 0.11% | Not reported | Q4 2018 | |
| $19.1M | 0.09% | 0.33% | New | Q2 2026 | |
| $17.8M | 0.08% | 0.35% | Not reported | Q2 2024 | |
| $16.2M | 0.08% | 1.79% | +1189.5% | Q1 2026 | |
| $15.3M | 0.07% | Not reported | -75.9% | Q1 2020 | |
| $15.2M | 0.07% | 0.00% | -31.5% | Q3 2022 | |
| $14.2M | 0.07% | 0.05% | Not reported | Q3 2018 | |
| $13.9M | 0.06% | Not reported | -14.5% | Q2 2020 | |
| $13.8M | 0.06% | 0.02% | Not reported | Q1 2018 | |
| $13.3M | 0.06% | 0.02% | -16.7% | Q4 2018 | |
| $13.2M | 0.06% | 0.09% | +1745.2% | Q3 2018 | |
| $12.9M | 0.06% | 0.02% | +229.6% | Q1 2025 | |
| $12.8M | 0.06% | 0.08% | +20.8% | Q1 2022 | |
| $12.7M | 0.06% | 0.00% | +236.0% | Q2 2022 | |
| $12.6M | 0.06% | 0.01% | Not reported | Q3 2019 | |
| $12.2M | 0.06% | 0.06% | +86.8% | Q1 2021 | |
| $12.1M | 0.06% | 0.14% | +190.6% | Q3 2025 | |
| $11.5M | 0.05% | 0.01% | +181.5% | Q1 2025 | |
| $11.4M | 0.05% | 0.00% | New | Q2 2026 | |
| $11.1M | 0.05% | 0.47% | Not reported | Q2 2025 | |
| $10.9M | 0.05% | 0.00% | Not reported | Q1 2018 | |
| $10.9M | 0.05% | 0.28% | +613.0% | Q4 2019 | |
| $10.8M | 0.05% | 1.34% | +125.3% | Q1 2026 | |
| $10.7M | 0.05% | 0.56% | -53.0% | Q4 2021 | |
| $10.4M | 0.05% | Not reported | New | Q2 2026 | |
| $10.4M | 0.05% | 0.06% | Not reported | Q3 2023 | |
| $10.3M | 0.05% | 0.00% | +349.1% | Q3 2018 | |
| $9.66M | 0.05% | 0.01% | +141.5% | Q3 2022 | |
| TBLDTopBuild Corp | $9.45M | 0.04% | 0.09% | New | Q2 2026 |
| $9.14M | 0.04% | 2.28% | +13.3% | Q2 2024 | |
| $8.94M | 0.04% | 0.10% | +57.6% | Q4 2019 | |
| $8.75M | 0.04% | 0.02% | -7.8% | Q4 2018 | |
| $8.68M | 0.04% | 0.93% | +73.5% | Q2 2023 | |
| CHSKYChampion Homes, Inc. | $8.55M | 0.04% | 0.18% | Not reported | Q4 2019 |
| $8.4M | 0.04% | 0.98% | +32.1% | Q2 2024 | |
| $8.26M | 0.04% | 0.13% | +229.2% | Q1 2018 | |
| $7.93M | 0.04% | Not reported | +30.6% | Q4 2021 | |
| $7.88M | 0.04% | 0.08% | +16626.7% | Q2 2024 | |
| $7.67M | 0.04% | 0.04% | +241.1% | Q4 2024 | |
| Q1 2026Reported May 15, 2026503 positions | |||||
| $263M | 1.54% | 0.01% | +29.9% | Q4 2021 | |
| $138M | 0.81% | 219.90% | +981.7% | Q2 2022 | |
| $111M | 0.65% | 0.01% | -0.1% | Q3 2021 | |
| $107M | 0.62% | 0.00% | -10.7% | Q1 2020 | |
| $64.4M | 0.38% | Not reported | Not reported | Q1 2020 | |
| $51.6M | 0.30% | 0.14% | Not reported | Q1 2018 | |
| $44.1M | 0.26% | 0.18% | +35.2% | Q3 2021 | |
| $30.5M | 0.18% | Not reported | Not reported | Q2 2024 | |
| $25.6M | 0.15% | 0.43% | +23.4% | Q4 2025 | |
| $24.4M | 0.14% | 0.00% | +41.3% | Q1 2020 | |
| $23.5M | 0.14% | 0.03% | +311.4% | Q4 2018 | |
| $21.4M | 0.13% | 0.00% | Not reported | Q3 2022 | |
| $20.4M | 0.12% | 0.01% | -72.1% | Q3 2020 | |
| $20.1M | 0.12% | 0.02% | +492.0% | Q1 2022 | |
| $20M | 0.12% | 1.30% | +601.2% | Q4 2022 | |
| $19.9M | 0.12% | 0.18% | Not reported | Q1 2020 | |
| $17.4M | 0.10% | 0.00% | Not reported | Q1 2018 | |
| $16.1M | 0.09% | 0.20% | +775.0% | Q2 2019 | |
| $14.7M | 0.09% | 0.03% | +19.9% | Q4 2020 | |
| $14.7M | 0.09% | Not reported | Not reported | Q2 2021 | |
| $14.5M | 0.08% | 0.61% | New | Q1 2026 | |
| $14.4M | 0.08% | 0.26% | +1794.2% | Q4 2019 | |
| $14.1M | 0.08% | 0.00% | +90.4% | Q2 2018 | |
| STSLNOSoleno Therapeutics Inc | $14.1M | 0.08% | 0.81% | +898.0% | Q1 2024 |
| $14M | 0.08% | 0.23% | Not reported | Q2 2024 | |
| $13.4M | 0.08% | 0.01% | +45.7% | Q3 2024 | |
| $11.6M | 0.07% | 0.01% | Not reported | Q1 2025 | |
| CPCNTACentessa Pharmaceuticals PLC | $10.9M | 0.06% | 0.18% | Not reported | Q1 2025 |
| $10.6M | 0.06% | 0.09% | Not reported | Q4 2019 | |
| $10.6M | 0.06% | 0.01% | New | Q1 2026 | |
| $10.6M | 0.06% | 0.68% | +82.9% | Q1 2018 | |
| $10.5M | 0.06% | 0.24% | Not reported | Q1 2019 | |
| $10.4M | 0.06% | 0.60% | +135.2% | Q4 2025 | |
| $10.4M | 0.06% | 0.31% | +5507.1% | Q2 2020 | |
| $9.95M | 0.06% | 0.02% | +0.4% | Q2 2021 | |
| $9.52M | 0.06% | Not reported | Not reported | Q2 2020 | |
| $9.49M | 0.06% | 0.02% | +1541.4% | Q2 2019 | |
| $9.42M | 0.06% | 0.01% | Not reported | Q4 2023 | |
| $9.38M | 0.05% | 0.00% | -75.7% | Q4 2019 | |
| $8.9M | 0.05% | 1.19% | Not reported | Q4 2021 | |
| $8.77M | 0.05% | 0.10% | +43.2% | Q4 2023 | |
| $8.44M | 0.05% | 0.02% | +330.9% | Q4 2018 | |
| $8.08M | 0.05% | 0.03% | -11.8% | Q4 2025 | |
| $7.64M | 0.04% | 0.02% | New | Q1 2026 | |
| $7.63M | 0.04% | 0.31% | Not reported | Q4 2022 | |
| $7.63M | 0.04% | 0.47% | Not reported | Q1 2023 | |
| $7.56M | 0.04% | 0.00% | +440.5% | Q4 2023 | |
| $7.5M | 0.04% | 0.01% | Not reported | Q1 2020 | |
| $7.45M | 0.04% | 0.78% | +58.8% | Q2 2024 | |
| $7.33M | 0.04% | 0.00% | +109.3% | Q1 2019 | |
| Q4 2025Reported Feb 17, 2026513 positions | |||||
| $217M | 1.48% | 0.00% | +132.2% | Q4 2021 | |
| $135M | 0.93% | 0.01% | -14.3% | Q3 2021 | |
| $133M | 0.91% | 0.01% | Not reported | Q1 2020 | |
| $128M | 0.88% | 0.00% | Not reported | Q1 2020 | |
| $125M | 0.85% | Not reported | +81.5% | Q3 2020 | |
| $71.3M | 0.49% | 0.02% | Not reported | Q3 2020 | |
| $50.4M | 0.35% | 0.00% | Not reported | Q4 2019 | |
| $35M | 0.24% | 0.01% | +1854.1% | Q1 2022 | |
| $32.1M | 0.22% | 0.01% | Not reported | Q4 2024 | |
| $29.5M | 0.20% | Not reported | +0.2% | Q2 2024 | |
| $29M | 0.20% | 0.03% | Not reported | Q4 2017 | |
| $26.8M | 0.18% | 0.13% | +39.4% | Q3 2021 | |
| $22.9M | 0.16% | 0.05% | +9153.7% | Q3 2024 | |
| $22.6M | 0.16% | 0.06% | +160393.8% | Q4 2018 | |
| $20.9M | 0.14% | 20.33% | +128.2% | Q2 2022 | |
| $20.8M | 0.14% | 0.45% | -31.5% | Q2 2021 | |
| $19.7M | 0.13% | 0.01% | Not reported | Q4 2018 | |
| $19.1M | 0.13% | 0.40% | Not reported | Q1 2025 | |
| $18.8M | 0.13% | 0.00% | Not reported | Q1 2020 | |
| $18.3M | 0.13% | 0.61% | Not reported | Q1 2022 | |
| $17.6M | 0.12% | 0.03% | +6.2% | Q4 2019 | |
| $17.3M | 0.12% | 0.07% | +1030.3% | Q4 2018 | |
| $16.4M | 0.11% | Not reported | +109.5% | Q2 2020 | |
| SOSOCSable Offshore Corp. | $13.6M | 0.09% | 1.04% | +6.4% | Q4 2024 |
| $13.3M | 0.09% | 0.01% | +2649.4% | Q2 2021 | |
| $12.8M | 0.09% | 0.02% | +25.6% | Q2 2021 | |
| $12.7M | 0.09% | 0.38% | New | Q4 2025 | |
| CACWANClearwater Analytics Holdings, Inc. | $11.8M | 0.08% | Not reported | New | Q4 2025 |
| $11.8M | 0.08% | 0.03% | +15852.1% | Q1 2019 | |
| $11.6M | 0.08% | 0.00% | Not reported | Q1 2020 | |
| APAVDLAvadel Pharmaceuticals PLC | $11.6M | 0.08% | 0.55% | +74.1% | Q3 2020 |
| $11.4M | 0.08% | 0.00% | -27.5% | Q3 2024 | |
| CCMAComerica Inc | $11.3M | 0.08% | 0.10% | -8.9% | Q1 2020 |
| $11.3M | 0.08% | 0.02% | +25.2% | Q2 2020 | |
| $11.2M | 0.08% | 0.00% | +1154.8% | Q3 2024 | |
| $10.8M | 0.07% | 0.30% | +252.7% | Q3 2020 | |
| $10.8M | 0.07% | 0.03% | +10.4% | Q2 2021 | |
| $10.5M | 0.07% | 0.09% | Not reported | Q2 2020 | |
| $10.5M | 0.07% | 0.10% | -36.6% | Q3 2023 | |
| $10.5M | 0.07% | 0.27% | +47.4% | Q3 2023 | |
| $10M | 0.07% | 0.02% | Not reported | Q4 2020 | |
| $9.81M | 0.07% | 0.13% | +423.8% | Q3 2024 | |
| $9.62M | 0.07% | 0.16% | +599.8% | Q4 2021 | |
| $9.33M | 0.06% | 0.04% | +960.0% | Q4 2019 | |
| $9.22M | 0.06% | 0.01% | Not reported | Q1 2020 | |
| $9.21M | 0.06% | 0.02% | +3.9% | Q3 2018 | |
| $9.13M | 0.06% | 0.81% | -16.2% | Q1 2023 | |
| $8.68M | 0.06% | 0.01% | -9.7% | Q4 2018 | |
| $8.59M | 0.06% | 0.00% | -14.0% | Q2 2018 | |
| $8.33M | 0.06% | 2.38% | -4.5% | Q3 2018 | |
| Q3 2025Reported Nov 14, 2025559 positions | |||||
| $156M | 1.21% | 0.01% | +16.7% | Q3 2021 | |
| $126M | 0.98% | 0.01% | Not reported | Q1 2020 | |
| $93.3M | 0.73% | 0.00% | Not reported | Q4 2021 | |
| $53.3M | 0.42% | Not reported | -3.4% | Q3 2020 | |
| $40.5M | 0.32% | Not reported | +363.2% | Q2 2024 | |
| $31.9M | 0.25% | 0.88% | +192.8% | Q3 2020 | |
| $26.8M | 0.21% | 0.74% | +159.1% | Q4 2018 | |
| $25.8M | 0.20% | 0.66% | Not reported | Q2 2021 | |
| STSLNOSoleno Therapeutics Inc | $25M | 0.20% | 0.69% | +40.5% | Q1 2024 |
| SOSOCSable Offshore Corp. | $24.8M | 0.19% | 1.43% | +2309.6% | Q4 2024 |
| $23.8M | 0.19% | 0.07% | +591.4% | Q2 2020 | |
| $20.6M | 0.16% | Not reported | +709.4% | Q3 2023 | |
| $16.8M | 0.13% | 0.92% | +158.3% | Q4 2022 | |
| $16.6M | 0.13% | 0.09% | +117.1% | Q3 2021 | |
| $15.3M | 0.12% | 0.02% | Not reported | Q2 2021 | |
| $15M | 0.12% | 0.00% | +133.3% | Q3 2024 | |
| $14.7M | 0.11% | 0.17% | Not reported | Q3 2023 | |
| $13M | 0.10% | Not reported | Not reported | Q1 2018 | |
| $12.2M | 0.10% | 1.13% | Not reported | Q3 2024 | |
| $11.5M | 0.09% | 0.03% | Not reported | Q4 2019 | |
| $10.9M | 0.09% | 0.12% | +49.7% | Q2 2025 | |
| $10.5M | 0.08% | 0.07% | +14.4% | Q3 2020 | |
| $10.4M | 0.08% | 8.91% | Not reported | Q2 2022 | |
| $10.4M | 0.08% | 0.03% | Not reported | Q4 2019 | |
| $9.84M | 0.08% | 0.01% | Not reported | Q4 2018 | |
| CCMAComerica Inc | $9.76M | 0.08% | 0.11% | +14142.8% | Q1 2020 |
| $9.73M | 0.08% | 0.00% | -10.9% | Q2 2018 | |
| $9.63M | 0.08% | Not reported | Not reported | Q2 2022 | |
| $9.42M | 0.07% | 0.59% | +48.2% | Q1 2019 | |
| $9.35M | 0.07% | 2.40% | +536.8% | Q3 2018 | |
| $9.14M | 0.07% | 0.11% | +33.5% | Q1 2025 | |
| $9.01M | 0.07% | 0.96% | -15.1% | Q1 2023 | |
| $8.66M | 0.07% | 0.02% | Not reported | Q1 2018 | |
| $8.46M | 0.07% | 0.03% | +115.5% | Q2 2021 | |
| $8.3M | 0.06% | 0.01% | +65.0% | Q2 2020 | |
| $8.13M | 0.06% | 0.02% | +130.8% | Q3 2018 | |
| $7.8M | 0.06% | 0.01% | Not reported | Q2 2019 | |
| $7.47M | 0.06% | 0.42% | +95.6% | Q2 2019 | |
| $7.07M | 0.06% | 0.22% | Not reported | Q3 2023 | |
| $6.98M | 0.05% | 0.06% | Not reported | Q1 2021 | |
| APAPLSApellis Pharmaceuticals, Inc. | $6.9M | 0.05% | 0.24% | +32.1% | Q1 2021 |
| $6.8M | 0.05% | Not reported | -10.5% | Q2 2018 | |
| HHOLXHologic Inc | $6.74M | 0.05% | 0.04% | Not reported | Q4 2019 |
| $6.67M | 0.05% | 0.02% | +61.9% | Q3 2022 | |
| $6.6M | 0.05% | 0.00% | +1749.9% | Q3 2020 | |
| $6.51M | 0.05% | Not reported | +51.6% | Q2 2020 | |
| $6.08M | 0.05% | 0.01% | Not reported | Q1 2023 | |
| $6.02M | 0.05% | 0.09% | +148.9% | Q2 2018 | |
| $5.99M | 0.05% | 0.00% | Not reported | Q4 2018 | |
| $5.77M | 0.05% | 0.02% | -25.0% | Q3 2018 | |
Premium opens every quarter this fund has filed